We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current KYTX market cap is 502.12M. The company's latest EPS is USD -1.4787 and P/E is -8.34.
| Quarter End | Dec 2023 | ||
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | ||
| Operating Income | -21.38M | ||
| Net Income | -20.67M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.66M | 7.03M | 0 |
| Operating Income | -26.35M | -29.38M | -62.41M |
| Net Income | -26.35M | -28.89M | -60.37M |
| Quarter End | Dec 2023 | ||
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 75.2M | ||
| Total Liabilities | 26.02M | ||
| Total Equity | -131.4M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 85.49M | 66.92M | 75.2M |
| Total Liabilities | 23.02M | 20.25M | 26.02M |
| Total Equity | -46.25M | -74M | -131.4M |
| Market Cap | 502.12M |
| Price to Earnings Ratio | -8.34 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 14.53 |
| Price to Book Ratio | 10.24 |
| Dividend Yield | - |
| Shares Outstanding | 40.82M |
| Average Volume (1 week) | 252.13k |
| Average Volume (1 Month) | 418.87k |
| 52 Week Change | -64.09% |
| 52 Week High | 35.01 |
| 52 Week Low | 12.16 |
| Spread (Intraday) | 0.07 (0.57%) |
| Company Name | Kyverna Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://kyvernatx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
